Autoimmune-mediated atherothrombosis

Eiji Matsuura, L. R. Lopez

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Autoimmune vascular inflammation and oxidative stress (lipid peroxidation) are common in systemic autoimmune diseases and contribute to the oxidative modification of low-density lipoprotein (oxLDL) and oxLDL/β2GPI complex formation. Circulating oxLDL/β2GPI complexes have been detected in patients with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). The presence of antibodies to oxLDL/β2GPI complexes indicates that these complexes are immunogenic, and the coexistence of complexes and antibodies has pointed to an active proatherogenic role in the development of autoimmune vascular complications. Immunohistochemical staining of atherosclerotic lesions suggest that these complexes are formed in the arterial wall and released into circulation. The in vitro macrophage uptake of oxLDL/β2GPI complexes was significantly increased in the presence of antiphospholipid antibodies, either β2GPI-dependent anticardiolipin or anti-β2GPI antibodies, suggesting that macrophage Fcγ receptors are involved in lipid intracellular influx and foam cell formation. These findings provide an explanation for the accelerated development of atherosclerosis seen in SLE and APS. The presence of circulating oxLDL/β2GPI complexes and IgG antibodies to these complexes indicate significant vascular injury and oxidative stress as well as an active role in autoimmune-mediated atherothrombosis.

Original languageEnglish
Pages (from-to)878-887
Number of pages10
JournalLupus
Volume17
Issue number10
DOIs
Publication statusPublished - 2008

Fingerprint

LDL Lipoproteins
Antiphospholipid Syndrome
Systemic Lupus Erythematosus
Blood Vessels
Antibodies
Oxidative Stress
Macrophages
Foam Cells
Antiphospholipid Antibodies
Fc Receptors
Vascular System Injuries
Lipid Peroxidation
Autoimmune Diseases
Anti-Idiotypic Antibodies
Atherosclerosis
Immunoglobulin G
Staining and Labeling
Inflammation
Lipids

Keywords

  • Anticardiolipin antibodies
  • Antiphospholipid syndrome
  • Cardiovascular disease
  • Oxidized LDL
  • Thrombosis

ASJC Scopus subject areas

  • Rheumatology

Cite this

Autoimmune-mediated atherothrombosis. / Matsuura, Eiji; Lopez, L. R.

In: Lupus, Vol. 17, No. 10, 2008, p. 878-887.

Research output: Contribution to journalArticle

Matsuura, Eiji ; Lopez, L. R. / Autoimmune-mediated atherothrombosis. In: Lupus. 2008 ; Vol. 17, No. 10. pp. 878-887.
@article{c1849ea7f2954884a176d375e34d32bf,
title = "Autoimmune-mediated atherothrombosis",
abstract = "Autoimmune vascular inflammation and oxidative stress (lipid peroxidation) are common in systemic autoimmune diseases and contribute to the oxidative modification of low-density lipoprotein (oxLDL) and oxLDL/β2GPI complex formation. Circulating oxLDL/β2GPI complexes have been detected in patients with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). The presence of antibodies to oxLDL/β2GPI complexes indicates that these complexes are immunogenic, and the coexistence of complexes and antibodies has pointed to an active proatherogenic role in the development of autoimmune vascular complications. Immunohistochemical staining of atherosclerotic lesions suggest that these complexes are formed in the arterial wall and released into circulation. The in vitro macrophage uptake of oxLDL/β2GPI complexes was significantly increased in the presence of antiphospholipid antibodies, either β2GPI-dependent anticardiolipin or anti-β2GPI antibodies, suggesting that macrophage Fcγ receptors are involved in lipid intracellular influx and foam cell formation. These findings provide an explanation for the accelerated development of atherosclerosis seen in SLE and APS. The presence of circulating oxLDL/β2GPI complexes and IgG antibodies to these complexes indicate significant vascular injury and oxidative stress as well as an active role in autoimmune-mediated atherothrombosis.",
keywords = "Anticardiolipin antibodies, Antiphospholipid syndrome, Cardiovascular disease, Oxidized LDL, Thrombosis",
author = "Eiji Matsuura and Lopez, {L. R.}",
year = "2008",
doi = "10.1177/0961203308093553",
language = "English",
volume = "17",
pages = "878--887",
journal = "Lupus",
issn = "0961-2033",
publisher = "SAGE Publications Ltd",
number = "10",

}

TY - JOUR

T1 - Autoimmune-mediated atherothrombosis

AU - Matsuura, Eiji

AU - Lopez, L. R.

PY - 2008

Y1 - 2008

N2 - Autoimmune vascular inflammation and oxidative stress (lipid peroxidation) are common in systemic autoimmune diseases and contribute to the oxidative modification of low-density lipoprotein (oxLDL) and oxLDL/β2GPI complex formation. Circulating oxLDL/β2GPI complexes have been detected in patients with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). The presence of antibodies to oxLDL/β2GPI complexes indicates that these complexes are immunogenic, and the coexistence of complexes and antibodies has pointed to an active proatherogenic role in the development of autoimmune vascular complications. Immunohistochemical staining of atherosclerotic lesions suggest that these complexes are formed in the arterial wall and released into circulation. The in vitro macrophage uptake of oxLDL/β2GPI complexes was significantly increased in the presence of antiphospholipid antibodies, either β2GPI-dependent anticardiolipin or anti-β2GPI antibodies, suggesting that macrophage Fcγ receptors are involved in lipid intracellular influx and foam cell formation. These findings provide an explanation for the accelerated development of atherosclerosis seen in SLE and APS. The presence of circulating oxLDL/β2GPI complexes and IgG antibodies to these complexes indicate significant vascular injury and oxidative stress as well as an active role in autoimmune-mediated atherothrombosis.

AB - Autoimmune vascular inflammation and oxidative stress (lipid peroxidation) are common in systemic autoimmune diseases and contribute to the oxidative modification of low-density lipoprotein (oxLDL) and oxLDL/β2GPI complex formation. Circulating oxLDL/β2GPI complexes have been detected in patients with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). The presence of antibodies to oxLDL/β2GPI complexes indicates that these complexes are immunogenic, and the coexistence of complexes and antibodies has pointed to an active proatherogenic role in the development of autoimmune vascular complications. Immunohistochemical staining of atherosclerotic lesions suggest that these complexes are formed in the arterial wall and released into circulation. The in vitro macrophage uptake of oxLDL/β2GPI complexes was significantly increased in the presence of antiphospholipid antibodies, either β2GPI-dependent anticardiolipin or anti-β2GPI antibodies, suggesting that macrophage Fcγ receptors are involved in lipid intracellular influx and foam cell formation. These findings provide an explanation for the accelerated development of atherosclerosis seen in SLE and APS. The presence of circulating oxLDL/β2GPI complexes and IgG antibodies to these complexes indicate significant vascular injury and oxidative stress as well as an active role in autoimmune-mediated atherothrombosis.

KW - Anticardiolipin antibodies

KW - Antiphospholipid syndrome

KW - Cardiovascular disease

KW - Oxidized LDL

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=59649087488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59649087488&partnerID=8YFLogxK

U2 - 10.1177/0961203308093553

DO - 10.1177/0961203308093553

M3 - Article

C2 - 18827052

AN - SCOPUS:59649087488

VL - 17

SP - 878

EP - 887

JO - Lupus

JF - Lupus

SN - 0961-2033

IS - 10

ER -